Gastric inhibitory polypeptide

DB15217Investigational

Gastric inhibitory polypeptide is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).

Mechanism: Pharmacologically active on Gastric inhibitory polypeptide receptor
Curator reviewed
Also known as: GIP · GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE

Resolves to

Compound

UNII1O4H75S7H2CAS100040-31-1

Targets

P48546GIPR

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

609Drug interactionsStructured to mechanism, not free text

20Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Gastric inhibitory polypeptide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account